跳至主要内容
临床试验/NCT06214689
NCT06214689招募中不适用

IDH1 and OCT4 Markers as a Prognostic Factor in Clinical Outcome of High Grade Astrocytic Glioma

Assiut University1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2024年9月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
35
试验地点
1
主要终点
IDH1 and OCT4 markers and their relation to postoperative prognosis of high grade astrocytoma patients

研究概览

简要总结

observation of IDH1 and OCT4 markers level and high grade astrocytoma patients prognosis after excision.

详细描述

explore the relationship between prognosis and IDH1 and OCT4 biomarkers after high grade astrocytoma excision , according to progression free survival and overall survival , in prospective and retrospective samples.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients of high grade astrocytic glioma patients fit for surgery

排除标准

  • patients of low grade glioma patients unfit for surgery

结局指标

主要结局

IDH1 and OCT4 markers and their relation to postoperative prognosis of high grade astrocytoma patients

时间窗: baseline

explore the relationship between prognosis (progression free and overall survival ) and biomarkers (IDH1 and OCT4 ) after excision of high grade astrocytoma

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdelrahman Ata Salama Swefy

doctor

Assiut University

研究点 (1)

Loading locations...

相似试验